CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicentre Pharmacokinetics and Pharmacodynamics Population Study.

Dahyot-Fizelier C, Chauzy A, Chalard K, Bernard F, de Courson H, Leblanc PE, Francony G, Chabanne R, Lakhal K, Cinotti R, Gregoire C, Pottecher J, Bouhemad B, Merlaud A, Adier C, Lecron JC, Remy O, Couet W, Gregoire N, Marchand S, Atlanréa Study Group and PK-Pop-LCR Study Group.

Open source

DOI
10.1016/j.ijantimicag.2026.107969
Published
2026-08-17
Container
Int J Antimicrob Agents
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijantimicag.2026.107969,
  title = {CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicentre Pharmacokinetics and Pharmacodynamics Population Study.},
  author = {Dahyot-Fizelier C and  Chauzy A and  Chalard K and  Bernard F and  de Courson H and  Leblanc PE and  Francony G and  Chabanne R and  Lakhal K and  Cinotti R and  Gregoire C and  Pottecher J and  Bouhemad B and  Merlaud A and  Adier C and  Lecron JC and  Remy O and  Couet W and  Gregoire N and  Marchand S and  Atlanréa Study Group and PK-Pop-LCR Study Group.},
  year = {2026},
  journal = {Int J Antimicrob Agents},
  doi = {10.1016/j.ijantimicag.2026.107969},
  url = {https://doi.org/10.1016/j.ijantimicag.2026.107969}
}

RIS

TY  - JOUR
TI  - CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicentre Pharmacokinetics and Pharmacodynamics Population Study.
AU  - Dahyot-Fizelier C
AU  -  Chauzy A
AU  -  Chalard K
AU  -  Bernard F
AU  -  de Courson H
AU  -  Leblanc PE
AU  -  Francony G
AU  -  Chabanne R
AU  -  Lakhal K
AU  -  Cinotti R
AU  -  Gregoire C
AU  -  Pottecher J
AU  -  Bouhemad B
AU  -  Merlaud A
AU  -  Adier C
AU  -  Lecron JC
AU  -  Remy O
AU  -  Couet W
AU  -  Gregoire N
AU  -  Marchand S
AU  -  Atlanréa Study Group and PK-Pop-LCR Study Group.
PY  - 2026
JO  - Int J Antimicrob Agents
DO  - 10.1016/j.ijantimicag.2026.107969
UR  - https://doi.org/10.1016/j.ijantimicag.2026.107969
ER  - 

APA

C, D., A, C., K, C., F, B., H, D. C., PE, L., G, F., R, C., K, L., R, C., C, G., J, P., B, B., A, M., C, A., JC, L., O, R., W, C., N, G., S, M., & Group., A. S. G. A. P. S. (2026). CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicentre Pharmacokinetics and Pharmacodynamics Population Study.. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2026.107969

Source records